The Effects of Cilnidipine on Metabolic Syndrome Improvement

NCT00325936 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Metabolic Syndrome X

Interventions

DRUG: Cilnidipine

Sponsor

Boryung Pharmaceutical Co., Ltd